Trader’s Buzz: Gevo (GEVO), Yahoo Inc. (YHOO), OvaScience (OVAS), Quality Distribution (QLTY), Ann Inc. (ANN)

Shares of Gevo, Inc. (GEVO) are surging $1.30, or 53%, to $3.75 in early trading on Thursday after the company announced today the signing of a strategic alliance agreement with Alaska Airlines (ALK) to purchase Gevo’s renewable jet fuel and fly the first-ever commercial flight on alcohol-to-jet fuel.

Gevo said the demonstration flight is expected to occur after it receives ASTM International certification for its fuel, sometime in mid to late 2015.

Yahoo! Inc. (YHOO) shares are up 8% to $45.03 after Thursday’s open, lifted by its stake in Alibaba (BABA). Shares of Alibaba Group Holding surged in Thursday premarket trade after the Chinese e-commerce giant reported Q4 results that beat Wall Street’s consensus estimates.

OvaScience (OVAS) shares spiked nearly 14% to $27.78 in early trading after the global fertility company announced today that one of the first patients who received its AUGMENTSM treatment gave birth to a healthy baby boy in Toronto, Ontario, Canada.

“Before my husband and I learned about the AUGMENT treatment, we struggled with infertility due to my egg quality and felt somewhat discouraged,” said the mother. “Now we are optimistic that our experience will show couples, especially those who suffer from poor egg health, that they have a new option to have their own biological child.”

Quality Distribution Inc. (QLTY) stock was exploding higher by more than 61% Thursday after the North American logistics and transportation provider announced agreement to be acquired by funds Advised by Apax Partners, a global private equity firm, for $16.00 per share in all cash.

Ann Inc. (ANN) shares rallied $2.42, or 6.45%, to $39.92 in early trading Thursday on reports the company is in talks to sell itself to Golden Gate Capital for about $2 billion.

A deal for the New York-based $1.82 billion market cap company could come together as early as next week should the negotiations prove successful.

Be the first to comment

Leave a Reply

Your email address will not be published.


*